<code id='F73B0F189E'></code><style id='F73B0F189E'></style>
    • <acronym id='F73B0F189E'></acronym>
      <center id='F73B0F189E'><center id='F73B0F189E'><tfoot id='F73B0F189E'></tfoot></center><abbr id='F73B0F189E'><dir id='F73B0F189E'><tfoot id='F73B0F189E'></tfoot><noframes id='F73B0F189E'>

    • <optgroup id='F73B0F189E'><strike id='F73B0F189E'><sup id='F73B0F189E'></sup></strike><code id='F73B0F189E'></code></optgroup>
        1. <b id='F73B0F189E'><label id='F73B0F189E'><select id='F73B0F189E'><dt id='F73B0F189E'><span id='F73B0F189E'></span></dt></select></label></b><u id='F73B0F189E'></u>
          <i id='F73B0F189E'><strike id='F73B0F189E'><tt id='F73B0F189E'><pre id='F73B0F189E'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:Wikipedia    Page View:216
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In